Correlation Between TC BioPharm and BioSig Technologies,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TC BioPharm and BioSig Technologies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TC BioPharm and BioSig Technologies, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TC BioPharm plc and BioSig Technologies, Common, you can compare the effects of market volatilities on TC BioPharm and BioSig Technologies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TC BioPharm with a short position of BioSig Technologies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of TC BioPharm and BioSig Technologies,.

Diversification Opportunities for TC BioPharm and BioSig Technologies,

-0.64
  Correlation Coefficient

Excellent diversification

The 3 months correlation between TCBPW and BioSig is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding TC BioPharm plc and BioSig Technologies, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioSig Technologies, and TC BioPharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TC BioPharm plc are associated (or correlated) with BioSig Technologies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioSig Technologies, has no effect on the direction of TC BioPharm i.e., TC BioPharm and BioSig Technologies, go up and down completely randomly.

Pair Corralation between TC BioPharm and BioSig Technologies,

Assuming the 90 days horizon TC BioPharm is expected to generate 3.2 times less return on investment than BioSig Technologies,. In addition to that, TC BioPharm is 1.65 times more volatile than BioSig Technologies, Common. It trades about 0.05 of its total potential returns per unit of risk. BioSig Technologies, Common is currently generating about 0.24 per unit of volatility. If you would invest  30.00  in BioSig Technologies, Common on October 4, 2024 and sell it today you would earn a total of  119.00  from holding BioSig Technologies, Common or generate 396.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.39%
ValuesDaily Returns

TC BioPharm plc  vs.  BioSig Technologies, Common

 Performance 
       Timeline  
TC BioPharm plc 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in TC BioPharm plc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, TC BioPharm showed solid returns over the last few months and may actually be approaching a breakup point.
BioSig Technologies, 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in BioSig Technologies, Common are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady technical and fundamental indicators, BioSig Technologies, displayed solid returns over the last few months and may actually be approaching a breakup point.

TC BioPharm and BioSig Technologies, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TC BioPharm and BioSig Technologies,

The main advantage of trading using opposite TC BioPharm and BioSig Technologies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TC BioPharm position performs unexpectedly, BioSig Technologies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioSig Technologies, will offset losses from the drop in BioSig Technologies,'s long position.
The idea behind TC BioPharm plc and BioSig Technologies, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
CEOs Directory
Screen CEOs from public companies around the world
Stocks Directory
Find actively traded stocks across global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon